Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BMP1 | P13497 | 6/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 4/20 | 0.33 |
| ▸ | REN | P00797 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6983470 | 0.93 | BMP1 (0.39) | BMP1MMP2LMNARENMAPK14 | |
| SCHEMBL6982858 | 0.93 | MMP1 (0.38) | MAPTLMNASLC2A1TP53REN | |
| SCHEMBL6981709 | 0.88 | BMP1 (0.38) | BMP1MMP2RENPSMB5 | |
| SCHEMBL6981390 | 0.86 | BMP1 (0.37) | BMP1MMP2REN | |
| SCHEMBL6987232 | 0.86 | BMP1 (0.37) | BMP1MMP2RENPSMB5 | |
| SCHEMBL6986124 | 0.83 | CTSS (0.36) | BMP1MMP2REN | |
| SCHEMBL6981862 | 0.81 | BMP1 (0.38) | BMP1MMP2MAPTLMNATP53 | |
| SCHEMBL6986904 | 0.80 | REN (0.36) | BMP1MMP2REN | |
| SCHEMBL6979967 | 0.79 | BMP1 (0.33) | BMP1MMP2LMNARENPSMB5 | |
| SCHEMBL6982289 | 0.79 | MMP1 (0.37) | REN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1089964-B1 | HYDRAZINE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2003-10-29 | — | — | EP | disclosed |
| US-6239151-B1 | TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES, OSTEOARTHRITIS, RESPIRATORY DISEASES, TUMORS, CACHEXIA, CARDIOVASCULAR DISEASES, FEVER, HAEMORRHAGE AND SEPSIS, HYDRAZINE DERIVATIVES, | HOFFMANN-LA ROCHE INC. | 2001-05-29 | — | — | US | disclosed |